DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, extendable to three years under certain conditions. Orphan drug exclusivity is ...

The articles in this issue reflect an industry in transition, committed to innovation while ensuring safe, reliable, and forward-looking pharmaceutical production. Susan J. Schniepp, distinguished ...

Talking about research and development for the pharmaceutical and cosmetics industries used to conjure up images of scientists isolated in laboratories. Today, digital technology is set to change the ...